Clinical Dilemmas in Viral Liver Disease (PDF)

Investigating the liver Non-invasive markers of fibrosis - useful or useless? Liver biopsy in HCV with easy to treat disease - should we bother? The inactive carrier - what tests should we do for HBeAg negative patients with minimal HBV DNA and near normal LFTs? Screening for HCC in patients with viral cirrhosis - is ultrasound enough ? HBV pre-treatment sequencing. Prudent precaution or unnecessary luxury? Genomic investigations in viral hepatitis - likely to help or hinder? Today's therapies i) HCV How should HCV Genotype 1 Non-responders be managed? How should HCV Genotype 1 patients who relapse or breakthrough be managed? How should HCV Genotype 2/3 Non-responders be managed? How should HCV Genotype 2/3 patients who relapse or breakthrough be managed? How should we treat acute HCV infection? How should we treat HCV in patients with red cell dyscrasias? How should we treat HCV in dialysis patients? How should we treat HCV in patients with a renal transplant? How should we treat HCV in psychotic patients? What management strategies can we use for morbid obesity and HCV? What management strategies are appropriate for Cytopenias and hepatitis C? How should patients with multiple HCV genotypes be managed? How should we treat HCV in injecting drug users? How should we treat HIC and HCV/HBV? How should we treat HCV, anti LKM antibodies and autoimmune disorders? How should we manage an easy to treat virus in difficult patients? -HCV in obese cirrhotics with genotype 3 How should we treat HCV in children? Controlling symptoms in chronic HCV ON AND OFF TREATMENT - does anything work ? Complementary therapies in chronic HCV - exploitation or something to offer ? HCV in the post liver transplant patient: what options do we have? How should we manage viral hepatitis in bone marrow transplant patients? ii) HBV What's the best way to manage acute HBV? How should we manage HBeAg positive patients with near normal LFTs? How should we manage HBeAg negative patients with minimal

Graham R Foster PhD FRCP

Professor of Hepatology, Queen Marys University of London,
Blizard Institute of Cell & Molecular Science, The Royal London
Hospital, London, UK

K. Rajender Reddy MD, FACP, FACG, FRCP

Professor of Medicine, Professor of Medicine in
Surgery, Director of Hepatology, Medical Director of Liver
Transplantation, University of Pennsylvania, PA, USA

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.